Ningbo Menovo Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 578.28 million compared to CNY 891.18 million a year ago. Revenue was CNY 582.26 million compared to CNY 897.31 million a year ago.

Net income was CNY 30.85 million compared to CNY 184.66 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to CNY 0.87 a year ago. Diluted earnings per share from continuing operations was CNY 0.13 compared to CNY 0.82 a year ago.